Percival Barretto-Ko
CIK: 0001978654
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SPRUCE BIOSCIENCES, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 21, 2026SPRB
SPRUCE BIOSCIENCES, INC.
Award(A)DirectStock Option (Right to Buy)
1.7K shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
Award(A)DirectStock Option (Right to Buy)
800 shares- - Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
Disposition(D)DirectStock Option (Right to Buy)
800 shares- - Jul 22, 2025SPRB
SPRUCE BIOSCIENCES, INC.
Award(A)DirectStock Option (Right to Buy)
30K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 | SPRB SPRUCE BIOSCIENCES, INC. | Award(A) Stock Option (Right to Buy) | 1,700 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Award(A) Stock Option (Right to Buy) | 800 | - | - | Direct |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Disposition(D) Stock Option (Right to Buy) | 800 | - | - | Direct |
| Jul 22, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | Award(A) Stock Option (Right to Buy) | 30,000 | - | - | Direct |
1-4 of 4 transactions
About Barretto-Ko Percival
Barretto-Ko Percival (SEC CIK 0001978654) files insider reports with the SEC as Director of SPRUCE BIOSCIENCES, INC. (SPRB).
Signal8 holds 3 ownership filings by Barretto-Ko Percival, all Form 4s, filed between Jul 24, 2025 and May 26, 2026. Those filings report 4 transactions, from Jul 22, 2025 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Barretto-Ko Percival's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Barretto-Ko Percival
- May 21, 2026: Grant or award of SPRB derivative securities (Form 4, code A).
- Dec 11, 2025: Grant or award of SPRB derivative securities (Form 4, code A).
- Dec 11, 2025: Disposition to issuer transaction of SPRB derivative securities (Form 4, code D).
- Jul 22, 2025: Grant or award of SPRB derivative securities (Form 4, code A).
Other insiders filing for SPRUCE BIOSCIENCES, INC. (SPRB)
- Quartel Adrian W, Chief Medical Officer
- Szwarcberg Javier B., CHIEF EXECUTIVE OFFICER
- SPIEGELMAN DANIEL K, Director
- SIMPSON CAMILLA V, Director
- GREY MICHAEL G, Executive Chairman
- Walbert Keli, Director